Rosemary Waring

(Former)

1 - 20 out of 81Page size: 20

Publications

  1. Published

    Cysteine dioxygenase: modulation of expression in human cell lines by cytokines with control of sulphate formation

    Rosemary Waring, 1 Aug 2002, In: Toxicology in Vitro. 16, 4, p. 481-483 3 p.

    Research output: Contribution to journal › Article

  2. Published

    Spot urinary creatinine in pervasive developmental disorders

    Rosemary Waring, 1 Jun 2006, In: Pediatrics International. 48, p. 292-297 6 p.

    Research output: Contribution to journal › Article

  3. Published

    Tetrodotoxin

    Mark Wheatley & Rosemary Waring, 1 Jan 2007, Molecules of death. Waring, RH., Steventon, GB. & Mitchell, SC. (eds.). 2nd ed. Imperial College Press

    Research output: Chapter in Book/Report/Conference proceeding › Chapter

  4. Published

    Mushroom toxins

    Rosemary Waring, Rosemary Waring, 1 Jan 2007, The molecules of death.

    Research output: Chapter in Book/Report/Conference proceeding › Chapter

  5. Published

    Spider Toxins

    Rosemary Waring, 1 Jan 2002, Molecules of Death . Waring, R., Steventon, G. & Mitchell, S. (eds.). Imperial College Press

    Research output: Chapter in Book/Report/Conference proceeding › Chapter

  6. Published

    Autism and ADHD: could diet affect the symptoms?

    Rosemary Waring, 1 Jan 2001, In: The Nutrition Practitioner. 3, p. 8-10 3 p.

    Research output: Contribution to journal › Article

  7. Published

    In vitro determination of endocrine disruption: Patent GB0719048.1 filed 29 Sept 2007

    Rosemary Waring & David Ramsden, 1 Jan 2007

    Research output: Patent

  8. Published

    Spider toxins

    Rosemary Waring, 1 Jan 2007, Molecules of death. Waring, R., Steventon, G. & Mitchell, S. (eds.). 2nd ed. Imperial College Press

    Research output: Chapter in Book/Report/Conference proceeding › Chapter

  9. Published

    Rheumatoid Arthritis Assay: UK Patent Application, filed July 20th 2005

    Rosemary Waring, David Ramsden, 1 Jan 2005

    Research output: Patent

  10. Published

    Editorial [ Environmental Impacts on Enzymes Involved in Drug and Steroid Metabolism Guest Editor: R.H. Waring ]

    Rosemary Waring, 1 May 2008, In: Current Drug Metabolism. 9, 4, p. 267-268 2 p.

    Research output: Contribution to journal › Editorial

  11. Published

    Endocrine disruptors - what are they and why is there so much interest?

    Rosemary Waring, 1 Mar 2007, In: Chimica Oggi / Chemistry Today. 25, 2, p. 34-36 3 p.

    Research output: Contribution to journal › Article

  12. Published

    Non-genomic effects of endocrine disrupters on dehydroepiandrosterone sulphotransferase and enzymes involve in PAPS synthesis

    Rosemary Waring, Chris Kirk, David Ramsden, 1 Jan 2007, In: Environmental Health Perspectives. In press

    Research output: Contribution to journal › Article

  13. Published

    Degradation to sulphate of S-methyl-L-cysteine sulphoxide and S-carboxymethyl-L-cysteine sulphoxide in man

    Rosemary Waring, 1 Jan 2003, In: Drug Metabolism and Drug Interactions. 19, p. 241-255 15 p.

    Research output: Contribution to journal › Article

  14. Published

    In utero exposure to carcinogens: epigenetics, developmental disruption and consequences in later life

    Rosemary Waring, Apr 2016, In: Maturitas. 86, p. 59-63

    Research output: Contribution to journal › Article › peer-review

  15. Published

    The Molecules of Death

    Rosemary Waring, 1 Jan 2007, World Scientific.

    Research output: Book/Report › Book

  16. Published

    4th Year Report for EC on ENDOMET programme: s

    Rosemary Waring, 1 Jan 2006

    Research output: Other contribution

  17. Published

    EC website: Final report for EC on ENDOMET programme

    Rosemary Waring, 1 Jan 2006

    Research output: Other contribution

  18. Published

    Sulphur anion metabolism in Rett syndrome patients

    Rosemary Waring, 1 Jan 2006, In: Journal of Pediatric Neurology. 4, p. 233-238 6 p.

    Research output: Contribution to journal › Article

  19. Published

    Endocrine disrupters: a human risk?

    Rosemary Waring, 1 Dec 2005, In: Molecular and Cellular Endocrinology. 244, 1-2, p. 2-9 8 p.

    Research output: Contribution to journal › Review article

  20. Published

    BIOMARKERS

    Rosemary Waring, 27 Sep 2012, Patent No. WO2012/127213

    Research output: Patent

Previous 1 2 3 4 5 Next